“…Lastly, to prepare (R,S)-13 and (S,S)-13, which are described as an unresolved diastereomeric mixture, 29 the Boc protecting group of the secondary alcohols (R,S)-24 and (S,S)-24 was reduced to methyl. The 1 H NMR signal of the exocyclic methine of the resulting N-methylamino alcohols (R,S)-28 and (S,S)-28, whose configurations are known because they are derived from (R,S)-24 28 and (S,S)-24, was a quartet of doublets and a quintet, respectively, thus confirming the previous configurations assignments to 8 Table 1 together with those previously reported for (S)-1, 23 (R,S)-2, 25 and (R,S)-3. 22 On the basis of their α4β2 affinity, two groups of compounds can be distinguished.…”
Section: ■ Introductionsupporting
confidence: 89%
“…Consistent with such results, our previous docking analysis showed similar interactions of the protonated pyrrolidine ring and of the benzodioxane substructure of (R,S)-2 and (R,S)-3 with α4 and β2 amino acid residues of the α4β2-nAChR binding pocket and, only for (R,S)-3, additional H-bonds between the 7-hydroxyl and two serines, Ser(111) and Ser(115) of the β2 subunit. 22,25 These additional bonds would be responsible for the increased potency and the β2 selectivity, while substitutions other than OH are found unproductive or deleterious apparently because only small substituents can be accepted at benzodioxane 7-position. 22 Compared to our pyrrolidinylbenzodioxanes, nicotinoids with a flexible oxymethylene bridge between the aromatic where I is the peak current amplitude induced by the agonist at concentration C, I max is the maximum response of the cell, nH the Hill coefficient, and EC 50 the concentration at which a half-maximum response is induced.…”
Section: ■ Discussionmentioning
confidence: 97%
“…22 The only one in a series of analogues with different 7-substituents to have nanomolar binding affinity, (R,S)-3 resulted from a SAR study on 2-(1′-methyl-2′-pyrrolidinyl)-1,4-benzodioxane (2), an α4β2-nAChR ligand with moderate submicromolar affinity when S configured at the pyrrolidine stereocenter, in turn designed by rigidifying the phenoxymethylene portion of the known nicotinic agonist Nmethylprolinol phenyl ether 1 23 in the 1,4-benzodioxane system (Chart 2). 24,25 The considerable enhancement of α4β2 affinity caused by the 7-OH substituent at the benzodioxane nucleus and the high α4β2 versus α3β4 functional selectivity of (R,S)-3 prompted us to study the effect of such a beneficial substitution also at the meta position of the conformationally free parent compound of 3, namely, the prolinol phenyl ether 1, and of two semirigid analogues of 3, the prolinol 2-methoxyphenyl ether 7 and the α-methylprolinol phenyl ether 8 (Chart 3). In addition to the phenyl ethers 1, 7, and 8 and their respective metahydroxylated analogues 4, 9, and 10, we also considered the azetidinyl analogue 5 of 4 and the pyridines 6, 11, 12, and 13, which are isosteres of 4, 7, and 8 (Chart 3).…”
Some unichiral analogues of 2R,2'S-2-(1'-methyl-2'-pyrrolidinyl)-7-hydroxy-1,4-benzodioxane, a potent and selective α4β2-nAChR partial agonist, were designed by opening dioxane and replacing hydroxyl carbon with nitrogen. The resulting 3-pyridyl and m-hydroxyphenyl ethers have high α4β2 affinity and good subtype selectivity, which get lost if OH is removed from phenyl or the position of pyridine nitrogen is changed. High α4β2 affinity and selectivity are also attained by meta hydroxylating the 3-pyridyl and the phenyl ethers of (S)-N-methylprolinol and the phenyl ether of (S)-2-azetidinemethanol, known α4β2 agonists, although the interaction mode of the aryloxymethylene substructure cannot be assimilated to that of benzodioxane. Indeed, the α4β2 and α3β4 functional tests well differentiate behaviors that the binding tests homologize: both the 3-hydroxyphenyl and the 5-hydroxy-3-pyridyl ether of N-methylprolinol are α4β2 full agonists, but only the latter is highly α4β2/α3β4 selective, while potent and selective partial α4β2 agonism characterizes the hydroxybenzodioxane derivative and its two opened semirigid analogues.
“…Lastly, to prepare (R,S)-13 and (S,S)-13, which are described as an unresolved diastereomeric mixture, 29 the Boc protecting group of the secondary alcohols (R,S)-24 and (S,S)-24 was reduced to methyl. The 1 H NMR signal of the exocyclic methine of the resulting N-methylamino alcohols (R,S)-28 and (S,S)-28, whose configurations are known because they are derived from (R,S)-24 28 and (S,S)-24, was a quartet of doublets and a quintet, respectively, thus confirming the previous configurations assignments to 8 Table 1 together with those previously reported for (S)-1, 23 (R,S)-2, 25 and (R,S)-3. 22 On the basis of their α4β2 affinity, two groups of compounds can be distinguished.…”
Section: ■ Introductionsupporting
confidence: 89%
“…Consistent with such results, our previous docking analysis showed similar interactions of the protonated pyrrolidine ring and of the benzodioxane substructure of (R,S)-2 and (R,S)-3 with α4 and β2 amino acid residues of the α4β2-nAChR binding pocket and, only for (R,S)-3, additional H-bonds between the 7-hydroxyl and two serines, Ser(111) and Ser(115) of the β2 subunit. 22,25 These additional bonds would be responsible for the increased potency and the β2 selectivity, while substitutions other than OH are found unproductive or deleterious apparently because only small substituents can be accepted at benzodioxane 7-position. 22 Compared to our pyrrolidinylbenzodioxanes, nicotinoids with a flexible oxymethylene bridge between the aromatic where I is the peak current amplitude induced by the agonist at concentration C, I max is the maximum response of the cell, nH the Hill coefficient, and EC 50 the concentration at which a half-maximum response is induced.…”
Section: ■ Discussionmentioning
confidence: 97%
“…22 The only one in a series of analogues with different 7-substituents to have nanomolar binding affinity, (R,S)-3 resulted from a SAR study on 2-(1′-methyl-2′-pyrrolidinyl)-1,4-benzodioxane (2), an α4β2-nAChR ligand with moderate submicromolar affinity when S configured at the pyrrolidine stereocenter, in turn designed by rigidifying the phenoxymethylene portion of the known nicotinic agonist Nmethylprolinol phenyl ether 1 23 in the 1,4-benzodioxane system (Chart 2). 24,25 The considerable enhancement of α4β2 affinity caused by the 7-OH substituent at the benzodioxane nucleus and the high α4β2 versus α3β4 functional selectivity of (R,S)-3 prompted us to study the effect of such a beneficial substitution also at the meta position of the conformationally free parent compound of 3, namely, the prolinol phenyl ether 1, and of two semirigid analogues of 3, the prolinol 2-methoxyphenyl ether 7 and the α-methylprolinol phenyl ether 8 (Chart 3). In addition to the phenyl ethers 1, 7, and 8 and their respective metahydroxylated analogues 4, 9, and 10, we also considered the azetidinyl analogue 5 of 4 and the pyridines 6, 11, 12, and 13, which are isosteres of 4, 7, and 8 (Chart 3).…”
Some unichiral analogues of 2R,2'S-2-(1'-methyl-2'-pyrrolidinyl)-7-hydroxy-1,4-benzodioxane, a potent and selective α4β2-nAChR partial agonist, were designed by opening dioxane and replacing hydroxyl carbon with nitrogen. The resulting 3-pyridyl and m-hydroxyphenyl ethers have high α4β2 affinity and good subtype selectivity, which get lost if OH is removed from phenyl or the position of pyridine nitrogen is changed. High α4β2 affinity and selectivity are also attained by meta hydroxylating the 3-pyridyl and the phenyl ethers of (S)-N-methylprolinol and the phenyl ether of (S)-2-azetidinemethanol, known α4β2 agonists, although the interaction mode of the aryloxymethylene substructure cannot be assimilated to that of benzodioxane. Indeed, the α4β2 and α3β4 functional tests well differentiate behaviors that the binding tests homologize: both the 3-hydroxyphenyl and the 5-hydroxy-3-pyridyl ether of N-methylprolinol are α4β2 full agonists, but only the latter is highly α4β2/α3β4 selective, while potent and selective partial α4β2 agonism characterizes the hydroxybenzodioxane derivative and its two opened semirigid analogues.
“…In 2009, we reported the synthesis of all the stereoisomers of 2-(2-pyrrolidinyl) benzodioxanes ( 21) and evaluated their binding affinities at the α4β2 nAChRs (Table 4) [24]. The two stereoisomers with absolute configuration "R" at the pyrrolidine stereocenter were devoid of affinity, while (S,S)-21 and (S,R)-21 had submicromolar α4β2 K i s of 0.47 µM and 0.26 µM, respectively.…”
Section: Structural Determinants For α4β2 Nachr Affinity and α4β2 Vs α3β4 Selectivity Of 7-substituted And Unsubstituted N-methyl Pyrrolimentioning
confidence: 99%
“…In the last 15 years, we have designed and developed some series of chiral α4β2 ligands, full and partial agonists and antagonists [22], initially linking the N-methyl-2pyrrolidinyl residue, typical of nicotinoids, to C(2) of 1,4-benzodioxane [23,24], a scaffold widely employed to design bioactive molecules [25][26][27][28][29] and, in this instance, to mimick the aryloxymethyl portion of prolinol aryl ethers, well known high-affinity α4β2 ligands such as A-84543 [30] (Figure 1B; for benzodioxane scaffold numbering see (S,R)-21 formula). Successive steps were the decoration of the benzodioxane by introducing substituents at its C (7) [31], deconstruction of the dioxane ring to give new phenyl and pyridyl ethers of prolinol [7,32], replacement of benzene with pyridine to give the four regioisomeric pyridodioxanes [5], and again benzodioxane decoration with substituents at C(6) and C(5) [33].…”
The selectivity of α4β2 nAChR agonists over the α3β4 nicotinic receptor subtype, predominant in ganglia, primarily conditions their therapeutic range and it is still a complex and challenging issue for medicinal chemists and pharmacologists. Here, we investigate the determinants for such subtype selectivity in a series of more than forty α4β2 ligands we have previously reported, docking them into the structures of the two human subtypes, recently determined by cryo-electron microscopy. They are all pyrrolidine based analogues of the well-known α4β2 agonist N-methylprolinol pyridyl ether A-84543 and differ in the flexibility and pattern substitution of their aromatic portion. Indeed, the direct or water mediated interaction with hydrophilic residues of the relatively narrower β2 minus side through the elements decorating the aromatic ring and the stabilization of the latter by facing to the not conserved β2-Phe119 result as key distinctive features for the α4β2 affinity. Consistently, these compounds show, despite the structural similarity, very different α4β2 vs. α3β4 selectivities, from modest to very high, which relate to rigidity/extensibility degree of the portion containing the aromatic ring and to substitutions at the latter. Furthermore, the structural rationalization of the rat vs. human differences of α4β2 vs. α3β4 selectivity ratios is here proposed.
RationaleProlinol aryl ethers and their rigidified analogues pyrrolidinyl benzodioxanes have a high affinity for mammalian a4β2 nicotinic acetylcholine receptors (nAChRs). Electrophysiological studies have shown that the former are full agonists and the latter partial agonists or antagonists of human a4β2 receptors, but their in vivo effects are unkown.
Objectives and MethodsAs a4b2 nAChRs play an important role in cognition and the rewarding effects of nicotine we tested the effects of two full agonists and one antagonist on spatial learning, memory and attention in zebrafish using a T-maze task and virtual object recognition test (VORT).The effect of a partial agonist in reducing nicotine-induced conditioned place preference (CPP), was also investigated.
ResultsIn comparison with the vehicle alone, the full agonists MCL-11 and MCL-28 induced a significant cognitive enhancement as measured by the reduced running time in the T-maze and increased attention as measured by the increased discrimination index in the VORT. MCL-11 was 882 times more potent than nicotine. The two compounds were characterised by an inverted U-shaped doseresponse curve, and their effects were blocked by the co-administration of the antagonist MCL-117, which alone had no effect. The partial agonist MCL-54 induced CPP and had an inverted U-shaped dose-response curve similar to that of nicotine, but blocked the reinforcing effect of co-administered nicotine. Binding studies showed that all of the compounds have a higher affinity for heteromeric [ 3 H]epibatidine receptors than [ 125 I]-aBungarotoxin receptors. MCL-11 was the most selective of heteromeric receptors.
Conclusions.These behavioural studies indicate that full-agonist prolinol aryl ethers, are very active in increasing spatial learning, memory and attention in zebrafish. The benzodioxane partial agonist MCL-54 reduced nicotine-induced CPP, and the benzodioxane antagonist MCL-117 blocked all agonistinduced activities.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.